Source: FinanzNachrichten

Voluntis: VOLUNTIS: Voluntis receives CE Mark for new version of Oleena with expanded clinical intelligence

New regulatory approval in the European Union for an enhanced version of Oleena extending its patient decision support algorithms New version now authorized for marketing in the United States and ...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Pierre Leurent's photo - Co-Founder & CEO of Voluntis

Co-Founder & CEO

Pierre Leurent

CEO Approval Rating

83/100

Read more